McFarlane Neil F.
SEC insider (Form 3/4/5 filer). CIK 0001681098. President and CEO at ZEVRA THERAPEUTICS, INC. (ZVRA). 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in BOSTON, MA.
Companies McFarlane Neil F. has filed insider reports for
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director, Officer, President and CEO
McFarlane Neil F.
CIK: 0001681098
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZEVRA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 12, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect20K shares at avg. $11.25$225K - Oct 10, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect50K shares- - Feb 9, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect14.6K shares at avg. $8.56$125K - Feb 7, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect37.5K shares- - Feb 2, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect91K shares at avg. $9.38$853K - Jan 31, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect233.3K shares- - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
250K shares- - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectRestricted Stock Unit
125K shares- - Oct 10, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect50K shares- - Oct 10, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect19.5K shares at avg. $10.82$211K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 20,000 | $11.25 | $224,948 | Direct |
| Oct 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 50,000 | - | $0 | Direct |
| Feb 9, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 14,625 | $8.56 | $125,186 | Direct |
| Feb 7, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 37,500 | - | $0 | Direct |
| Feb 2, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 91,000 | $9.38 | $853,425 | Direct |
| Jan 31, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 233,334 | - | $0 | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 250,000 | - | - | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Restricted Stock Unit | 125,000 | - | - | Direct |
| Oct 10, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 50,000 | - | - | Direct |
| Oct 10, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 19,500 | $10.82 | $210,908 | Direct |
1-10 of 15 transactions